Literature DB >> 29045710

Radiation-induced cognitive toxicity: pathophysiology and interventions to reduce toxicity in adults.

Christopher Wilke1, David Grosshans1, Joseph Duman1, Paul Brown1, Jing Li1.   

Abstract

Radiotherapy is ubiquitous in the treatment of patients with both primary brain tumors as well as disease which is metastatic to the brain. This therapy is not without cost, however, as cognitive decline is frequently associated with cranial radiation, particularly with whole brain radiotherapy (WBRT). The precise mechanisms responsible for radiation-induced morbidity remain incompletely understood and continue to be an active area of ongoing research. In this article, we review the hypothetical means by which cranial radiation induces cognitive decline as well as potential therapeutic approaches to prevent, minimize, or reverse treatment-induced cognitive deterioration. We additionally review advances in imaging modalities that can potentially be used to identify site-specific radiation-induced anatomic or functional changes in the brain and their correlation with clinical outcomes.

Entities:  

Mesh:

Year:  2018        PMID: 29045710      PMCID: PMC5892147          DOI: 10.1093/neuonc/nox195

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  76 in total

1.  Low-dose/dose-rate γ radiation depresses neural differentiation and alters protein expression profiles in neuroblastoma SH-SY5Y cells and C17.2 neural stem cells.

Authors:  Ainars Bajinskis; Heléne Lindegren; Lotta Johansson; Mats Harms-Ringdahl; Anna Forsby
Journal:  Radiat Res       Date:  2010-12-03       Impact factor: 2.841

2.  NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

Authors:  Roger Stupp; Eric T Wong; Andrew A Kanner; David Steinberg; Herbert Engelhard; Volkmar Heidecke; Eilon D Kirson; Sophie Taillibert; Frank Liebermann; Vladimir Dbalý; Zvi Ram; J Lee Villano; Nikolai Rainov; Uri Weinberg; David Schiff; Lara Kunschner; Jeffrey Raizer; Jerome Honnorat; Andrew Sloan; Mark Malkin; Joseph C Landolfi; Franz Payer; Maximilian Mehdorn; Robert J Weil; Susan C Pannullo; Manfred Westphal; Martin Smrcka; Lawrence Chin; Herwig Kostron; Silvia Hofer; Jeffrey Bruce; Rees Cosgrove; Nina Paleologous; Yoram Palti; Philip H Gutin
Journal:  Eur J Cancer       Date:  2012-05-18       Impact factor: 9.162

3.  Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul D Brown; Stephanie Pugh; Nadia N Laack; Jeffrey S Wefel; Deepak Khuntia; Christina Meyers; Ali Choucair; Sherry Fox; John H Suh; David Roberge; Vivek Kavadi; Soren M Bentzen; Minesh P Mehta; Deborah Watkins-Bruner
Journal:  Neuro Oncol       Date:  2013-08-16       Impact factor: 12.300

4.  Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.

Authors:  William J Magnuson; Nataniel H Lester-Coll; Abraham J Wu; T Jonathan Yang; Natalie A Lockney; Naamit K Gerber; Kathryn Beal; Arya Amini; Tejas Patil; Brian D Kavanagh; D Ross Camidge; Steven E Braunstein; Lauren C Boreta; Suresh K Balasubramanian; Manmeet S Ahluwalia; Niteshkumar G Rana; Albert Attia; Scott N Gettinger; Joseph N Contessa; James B Yu; Veronica L Chiang
Journal:  J Clin Oncol       Date:  2017-01-23       Impact factor: 44.544

Review 5.  GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality.

Authors:  W Danysz; C G Parsons; M Karcz-Kubicha; A Schwaier; P Popik; K Wedzony; J Lazarewicz; G Quack
Journal:  Amino Acids       Date:  1998       Impact factor: 3.520

6.  Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.

Authors:  Christina A Meyers; Jennifer A Smith; Andrea Bezjak; Minesh P Mehta; James Liebmann; Tim Illidge; Ian Kunkler; Jean-Michel Caudrelier; Peter D Eisenberg; Jacobus Meerwaldt; Ross Siemers; Christian Carrie; Laurie E Gaspar; Walter Curran; See-Chun Phan; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2004-01-01       Impact factor: 44.544

7.  Selective inhibition of microglia-mediated neuroinflammation mitigates radiation-induced cognitive impairment.

Authors:  Kenneth A Jenrow; Stephen L Brown; Karen Lapanowski; Hoda Naei; Andrew Kolozsvary; Jae Ho Kim
Journal:  Radiat Res       Date:  2013-04-05       Impact factor: 2.841

8.  Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.

Authors:  Masaaki Yamamoto; Toru Serizawa; Takashi Shuto; Atsuya Akabane; Yoshinori Higuchi; Jun Kawagishi; Kazuhiro Yamanaka; Yasunori Sato; Hidefumi Jokura; Shoji Yomo; Osamu Nagano; Hiroyuki Kenai; Akihito Moriki; Satoshi Suzuki; Yoshihisa Kida; Yoshiyasu Iwai; Motohiro Hayashi; Hiroaki Onishi; Masazumi Gondo; Mitsuya Sato; Tomohide Akimitsu; Kenji Kubo; Yasuhiro Kikuchi; Toru Shibasaki; Tomoaki Goto; Masami Takanashi; Yoshimasa Mori; Kintomo Takakura; Naokatsu Saeki; Etsuo Kunieda; Hidefumi Aoyama; Suketaka Momoshima; Kazuhiro Tsuchiya
Journal:  Lancet Oncol       Date:  2014-03-10       Impact factor: 41.316

9.  Central Nervous System Injury - A Newly Observed Bystander Effect of Radiation.

Authors:  Caitlin Feiock; Masashi Yagi; Adam Maidman; Aaron Rendahl; Susanta Hui; Davis Seelig
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

10.  P53 regulates disruption of neuronal development in the adult hippocampus after irradiation.

Authors:  Y-Q Li; Zw-C Cheng; Sk-W Liu; I Aubert; C S Wong
Journal:  Cell Death Discov       Date:  2016-10-03
View more
  17 in total

1.  Brain Damage and Patterns of Neurovascular Disorder after Ionizing Irradiation. Complications in Radiotherapy and Radiation Combined Injury.

Authors:  Nikolai V Gorbunov; Juliann G Kiang
Journal:  Radiat Res       Date:  2021-07-01       Impact factor: 2.841

2.  Feasibility of hippocampal dose-volume parameters associated with memory decline in intensity-modulated radiotherapy for supratentorial tumors.

Authors:  Shigeo Takahashi; Masahide Anada; Toshifumi Kinoshita; Takamasa Nishide; Shohei Kozai; Toru Shibata
Journal:  Mol Clin Oncol       Date:  2021-01-21

3.  The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis.

Authors:  Eva Elisabeth van Grinsven; Steven H J Nagtegaal; Joost J C Verhoeff; Martine J E van Zandvoort
Journal:  Oncol Res Treat       Date:  2021-09-03       Impact factor: 2.825

Review 4.  Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.

Authors:  Ayal A Aizer; Nayan Lamba; Manmeet S Ahluwalia; Kenneth Aldape; Adrienne Boire; Priscilla K Brastianos; Paul D Brown; D Ross Camidge; Veronica L Chiang; Michael A Davies; Leland S Hu; Raymond Y Huang; Timothy Kaufmann; Priya Kumthekar; Keng Lam; Eudocia Q Lee; Nancy U Lin; Minesh Mehta; Michael Parsons; David A Reardon; Jason Sheehan; Riccardo Soffietti; Hussein Tawbi; Michael Weller; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

5.  The correlations between psychological distress, cognitive impairment and quality of life in patients with brain metastases after whole-brain radiotherapy.

Authors:  Senbang Yao; He Zuo; Wen Li; Yinlian Cai; Qianqian Zhang; Lulian Pang; Yanyan Jing; Xiangxiang Yin; Huaidong Cheng
Journal:  Clin Transl Oncol       Date:  2022-08-29       Impact factor: 3.340

6.  Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse model.

Authors:  Dorela D Shuboni-Mulligan; Demarrius Young; Julianie De La Cruz Minyety; Nicole Briceno; Orieta Celiku; Amanda L King; Jeeva Munasinghe; Herui Wang; Kendra A Adegbesan; Mark R Gilbert; DeeDee K Smart; Terri S Armstrong
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

7.  Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus.

Authors:  Joshua D Palmer; Deepak Bhamidipati; Minesh Mehta; Noelle L Williams; Adam P Dicker; Maria Werner-Wasik; Wenyin Shi
Journal:  J Neurooncol       Date:  2018-08-07       Impact factor: 4.130

Review 8.  Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.

Authors:  Samantha J Mayo; Maryam Lustberg; Haryana M Dhillon; Zev M Nakamura; Deborah H Allen; Diane Von Ah; Michelle C Janelsins; Alexandre Chan; Karin Olson; Chia Jie Tan; Yi Long Toh; Jeong Oh; Lisa Grech; Yin Ting Cheung; Ishwaria Mohan Subbiah; Duska Petranovic; James D'Olimpio; Margherita Gobbo; Susanne Koeppen; Charles L Loprinzi; Linda Pang; Shivani Shinde; Olanipekun Ntukidem; Katherine B Peters
Journal:  Support Care Cancer       Date:  2020-11-24       Impact factor: 3.603

9.  A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS.

Authors:  Kellen Mulford; Chuyu Chen; Kathryn Dusenbery; Jianling Yuan; Matthew A Hunt; Clark C Chen; Paul Sperduto; Yoichi Watanabe; Christopher Wilke
Journal:  Clin Transl Radiat Oncol       Date:  2021-05-08

10.  Prior nasal delivery of antagomiR-122 prevents radiation-induced brain injury.

Authors:  Haihong Zhou; Furong Sun; Mingqian Ou; Yu Zhang; Meijun Lin; Liqin Song; Yangsheng Yu; Haojie Liao; Weihao Fan; Huaijie Xing; Minhua Li; Kui Zhao; Xiaolian Wu; Yuanhong Sun; Chunmei Liang; Yujie Cai; Lili Cui
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.